International Rare Cancers Initiative

被引:39
|
作者
Keat, Nicola [1 ]
Law, Kate [1 ]
Seymour, Matthew [2 ]
Welch, Jack [3 ]
Trimble, Ted [4 ]
Lascombe, Denis [5 ]
Negrouk, Anastassia [5 ]
机构
[1] Canc Res UK, London EC1V 4AD, England
[2] Univ Leeds, NCRN, Leeds, W Yorkshire, England
[3] NCI, Canc Therapy Evaluat Program, Div Canc Treatment & Diag, Bethesda, MD 20892 USA
[4] NCI, Ctr Global Hlth, Bethesda, MD 20892 USA
[5] European Org Res Treatment Canc, Brussels, Belgium
来源
LANCET ONCOLOGY | 2013年 / 14卷 / 02期
关键词
D O I
10.1016/S1470-2045(12)70570-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:109 / 110
页数:3
相关论文
共 50 条
  • [1] The international rare cancers initiative.
    Keat, Nicola Jane
    Law, Kate
    McConnell, Andrea
    Calvo, Fabian M.
    Negrouk, Anastasia
    Lacombe, Denis A.
    Welch, Jack
    Trimble, Edward Lloyd
    Gross, Thomas
    De Schaetzen, Gaetan
    Brachot, Jeanne-Mane
    Pauporta, Iris
    O'Riordan, Maura
    Seymour, Matthew T.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative
    Bogaerts, Jan
    Sydes, Matthew R.
    Keat, Nicola
    McConnell, Andrea
    Benson, Al
    Ho, Alan
    Rotha, Arnaud
    Fortpied, Catherine
    Eng, Cathy
    Peckitt, Clare
    Coens, Corneel
    Pettaway, Curtis
    Arnold, Dirk
    Hall, Emma
    Marshall, Ernie
    Sclafani, Francesco
    Hatcher, Helen
    Earl, Helena
    Ray-Coquard, Isabelle
    Paul, James
    Blay, Jean-Yves
    Whelan, Jeremy
    Panageas, Kathy
    Wheatley, Keith
    Harrington, Kevin
    Licitra, Lisa
    Billingham, Lucinda
    Hensley, Martee
    McCabe, Martin
    Patel, Poulam M.
    Carvajal, Richard
    Wilson, Richard
    Glynne-Jones, Rob
    McWilliams, Rob
    Leyvraz, Serge
    Rao, Sheela
    Nicholson, Steve
    Filiaci, Virginia
    Negrouk, Anastassia
    Lacombe, Denis
    Dupont, Elisabeth
    Pauporte, Iris
    Welch, John J.
    Law, Kate
    Trimble, Ted
    Seymour, Matthew
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (03) : 271 - 281
  • [3] Clinical research for rare cancers: is it a reality in the global regulatory landscape? The international rare cancer initiative
    Negrouk, Anastassia
    Lacombe, Denis
    Trimble, Edward L.
    Seymour, Matthew
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (05): : 433 - 440
  • [4] Validating prognostic models in metastatic uveal melanoma (MUM), an international rare cancers initiative
    Khoja, L.
    Atenafu, E.
    Joshua, A. M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] The international network of rare cancers (RCN, Rare Cancer Network)
    Mirimanoff, Rene-Olivier
    Thariat, Juliette
    Beikacemi, Yazid
    Villa, Salvodor
    Ozyar, Enis
    Krengli, Marco
    Miller, Robert C.
    Ozsahin, Mahmut
    BULLETIN DU CANCER, 2014, 101 (09) : 778 - 779
  • [6] Redefining Rare Genitourinary Cancers: An Initiative Led by the Global Society of Rare Genitourinary Tumors
    de Padua, Tiago Costa
    Monteiro, Fernando Sabino Marques
    Necchi, Andrea
    Spiess, Philippe E.
    EUROPEAN UROLOGY, 2024, 85 (05) : 414 - 416
  • [7] GLOBAL BALLAD: An International Rare Cancers Initiative trial to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma (IRCI 002).
    Evans, T. R. Jeffry
    Aparicio, Thomas
    Le Malicot, Karine
    Nakamura, Kenichi
    Honma, Yoshitaka
    McWilliams, Robert R.
    Ten Tije, Alberti.
    Anthoney, David Alan
    Boyd, Ruth
    Dixon-Hughes, Judith
    Graham, Janet Shirley
    Iveson, Timothy
    Nicoll, Jonathan
    Paul, James
    Salto-Tellez, Manuel
    Starling, Naureen
    Ueno, Makoto
    Yim, Kein
    Bridgewater, John A.
    Wilson, Richard H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Rare Cancers in Children - The EXPeRT Initiative: A Report from the European Cooperative Study Group on Pediatric Rare Tumors
    Bisogno, G.
    Ferrari, A.
    Bien, E.
    Brecht, I. B.
    Brennan, B.
    Cecchetto, G.
    Godzinski, J.
    Orbach, D.
    Reguerre, Y.
    Stachowicz-Stencel, T.
    Schneider, D. T.
    KLINISCHE PADIATRIE, 2012, 224 (06): : 416 - 420
  • [9] International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct
    Rao, Sheela
    Sclafani, Francesco
    Eng, Cathy
    Adams, Richard A.
    Guren, Marianne G.
    Sebag-Montefiore, David
    Benson, Al
    Bryant, Annette
    Peckitt, Clare
    Segelov, Eva
    Roy, Amitesh
    Seymour, Matt T.
    Welch, Jack
    Saunders, Mark P.
    Muirhead, Rebecca
    O'Dwyer, Peter
    Bridgewater, John
    Bhide, Shree
    Glynne-Jones, Rob
    Arnold, Dirk
    Cunningham, David
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (22) : 2510 - +
  • [10] Die International Rare Cancers InitiativeAktivitäten und Auswirkungen für die deutsche VersorgungslandschaftThe international rare cancers initiativeActivities and impact on the German healthcare landscape
    Peter Hohenberger
    Bernd Kasper
    Forum, 2017, 32 (1) : 26 - 31